1. |
第81回日本胃癌学会総会. 胃癌取扱い規約(改訂第14版) [M]. 東京: ファッi. ションタウン, 2009: 117.
|
2. |
第81回日本胃癌学会総会. 胃癌治療ガイドライン(改訂第3版) [M]. 東京: ファッションタウン, 2009: 111.
|
3. |
胃癌研究会. 胃癌取扱い規約(改訂第11版) [M]. 東京: 金原, 1985: 1213.
|
4. |
Chen JQ, Liu QH. Identification and classification of serosal invasion, as it relates to cancer cell shedding and surgical treatment in gastric cancer [J]. Semin Surg Oncol, 1994; 10(2): 107110.
|
5. |
陈峻青, 齐春莲, 单吉贤, 等. 胃癌浆膜的分型及其意义 [J]. 中华医学杂志, 1986; 66(12): 736738.
|
6. |
王振宁, 徐惠绵, 王舒宝, 等. 胃癌新TNM分期与其生物学行为及预后的关系 [J]. 中华外科杂志, 2000; 38(7): 493495.
|
7. |
Chen JQ, Zhang WF, Wang SB, et al . Some problems in the surgical treatment of gastric cancer [J]. Chin J Cancer Res, 1991; 3(3): 4552.
|
8. |
Huang BJ, Zheng XY, Wang ZN, et al . Prognostic significance of the number of metastatic lymph nodes: is UICC/TNM node classification perfectly suitable for early gastric cancer? [J]. Ann Surg Oncol, 2009; 16(1): 6167.
|
9. |
藤谷和正, 辻仲利政, 宮垣博道, 他. 非治癒胃癌に対する外科治療 [J]. 外科治療, 2007; 97(4): 393399.
|
10. |
陈峻青, 王舒宝, 单吉贤. 胃癌根治手术中三个主要问题的现状 [J]. 中国肿瘤临床, 1999; 26(5): 377380.
|
11. |
陈峻青, 夏志平. 胃肠癌手术学 [M]. 第2版. 北京: 人民卫生出版社, 2008: 36.
|
12. |
张文范, 张荫昌, 陈峻青. 胃癌 [M]. 第2版. 上海: 上海科技出版社, 2001: 8489.
|
13. |
单吉贤, 陈峻青, 张文范, 等. 胃癌手术切断端癌残留的临床特点及预防 [J]. 中华肿瘤杂志, 1991; 13(2): 139141.
|
14. |
陈峻青, 王舒宝, 齐春莲. 对胃癌手术中不同淋巴结清除术的合理评价 [J]. 中华医学杂志, 1995; 75(2): 110113.
|
15. |
Sobin LH, Wittekind CH. International Union Against Cancer (UICC): TNM Classification of malignant tumours [M]. 6th ed. New York: WileyLiss. 2002: 11.
|
16. |
深川剛生, 阪真, 田中則光, 他. 胃癌の予後予測因子 [J]. 臨床外科, 2009; 64(1): 4348.
|
17. |
Mimori K, Fukagawa T, Kosaka Y, et al. Hematogenous metastasis in gastric cancer requires isolated tumor cells and expression of vascular endothelial growth factor receptor1 [J]. Clin Cancer Res, 2008; 14(9): 26092616.
|
18. |
Mori K, Suzuki T, Uozaki H, et al. Detection of minimal gastric cancer cells in peritoneal washings by focused microarray analysis with multiple markers [J]. Ann Surg Oncol, 2007; 14(5): 16941702.
|
19. |
陈峻青. 胃癌综合治疗的新理念与新认识 [J]. 中华外科杂志, 2009; 47(17): 12811284.
|
20. |
Sakuramoto S, Sasako M, Yamaguchi T, et al. Adjuvant chemotherapy for gastric cancer with S1, an oral fluoropyrimidine [J]. N Engl J Med, 2007; 357(18): 18101820.
|
21. |
Cunningham D, Allum WH, Stenning SP, et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer [J]. N Engl J Med, 2006; 355(1): 1120.
|
22. |
Kawashima Y, Sasako M, Tsuburaya A, et al. Phase Ⅱ study of preoperative neoadjuvant chemotherapy (CX) with S1 plus cisplatin for gastric cancer (GC) with bulky and/or paraaortic lymph node metastases: A Japan Clinical Oncology Group Study (JCOG0405). Presented at the 2008 Gastrointestinal Cancers Symposium, Orlando, JPN, 2008.
|